C&L: RHEI names new CEO

RHEI Pharmaceuticals has named Dr. Geert Cauwenbergh as CEO.

Helicos BioSciences announced that Bill Efcavitch, Ph.D., has been named Helicos chief technology officer, Marc Levine has joined Helicos as senior vice president of product development and Stan Letovsky, Ph.D. has joined as vice president for scientific informatics.

Prometheus Laboratories has appointed Mark Spring as senior vice president and CFO.

Biovail named Peggy Mulligan its new CFO.

David Price has been named as the new CFO at Cornerstone BioPharma.

Ikaria Holdings named Stephen Ross senior vice president of commercial operations and James Briggs as senior vice president for human relations.

Intrexon has named Sunil Chada, Ph.D as the senior vice president of clinical research and development.

Sucampo Pharmaceuticals has appointed Kathryn Santis as its new vice president of investor relations and corporate communications.

Znomics has appointed Ofir Moreno as its new senior director of chemistry.

WuXi PharmaTech has promoted Rujian Ma to vice president of synthetic chemistry.

Joe Ciaffoni has accepted the position of chief communications officer for Atlanta-based Sciele Pharma.

Targanta Therapeutics has named StA(C)phane Bancel and Rosemary A. Crane to its board of directors.

Monogram Biosciences has named Christine A. White, M.D. to the company's board of directors.

GeoVax Labs has named Peter M. Tsolinas as a member of its board of directors.

Achillion Pharmaceuticals named Nicholas Simon to its board of directors.

PsychoGenics has named John McCall, Ph.D., as a member of its Scientific Advisory Board.